ArticleRadiation oncology (London, England)2022
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer.
Article in Radiation oncology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 46 citations in OpenAlex.
- Practical deep learning solutions for prostate cancer segmentation and implementation in radiotherapy planning.Physical and engineering sciences in medicine · 2026Article
- Deep learning for automatic detection of prostatectomy in CT images of prostate cancer patients.Physical and engineering sciences in medicine · 2026Article
- Clinical evaluation of novel deep learning-based auto-segmentation software: Utility and potential pitfalls.Journal of applied clinical medical physics · 2026Article
- Clinical edge-case stress testing of two Asia-developed AI auto-contouring systems using prostate radiotherapy planning CT images.Radiological physics and technology · 2026Article
- Charge Au@Pt NPs combined with 3D STS-Net for adaptive and sensitized radiotherapy of hepatocellular carcinoma: Synergistic enhancement of therapeutic gain across physical and biological dimensions.Bioactive materials · 2026Article
- Evaluating artificial intelligence versus human-generated contours in the thorax.Physics and imaging in radiation oncology · 2026Article
- Clinically validated deep learning auto-contouring for glioblastoma volumetric modulated arc therapy planning: a dosimetric equivalence study.Radiation oncology journal · 2026Article
- Article
- AI-driven precision diagnosis and treatment of prostate cancer: a narrative review.Frontiers in oncology · 2026Review
- Comment on "Deep learning in CT-based organ-at-risk delineation for pediatric flank irradiation": Methodological and clinical considerations.Clinical and translational radiation oncology · 2026Article
- Deep CNN-based Fully Automated Segmentation of Pelvic Multi-Organ on CT Images for Prostate Cancer Radiotherapy.Journal of biomedical physics & engineering · 2025Article
- The Role of Artificial Intelligence in Advancing Theranostics Dosimetry for Cancer Therapy: a Review.Nuclear medicine and molecular imaging · 2025Review
- Article
- Large-scale convolutional neural network for clinical target and multi-organ segmentation in gynecologic brachytherapy via multi-stage learning.Medical physics · 2025Article
- Deep learning-based delineation of whole-body organs at risk empowering adaptive radiotherapy.BMC medical informatics and decision making · 2025Article
- Point-cloud segmentation with in-silico data augmentation for prostate cancer treatment.Medical physics · 2025Article
- A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer.Clinical and translational radiation oncology · 2025Article
- Personalized deep learning auto-segmentation models for adaptive fractionated magnetic resonance-guided radiation therapy of the abdomen.Medical physics · 2025Article
- Large language model-augmented learning for auto-delineation of treatment targets in head-and-neck cancer radiotherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025Article
- The implementation of knowledge-based planning with partial OAR contours for prostate radiotherapy.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThe evaluation of automatic segmentation algorithms is commonly performed using geometric metrics. An analysis based on dosimetric parameters might be more relevant in clinical practice but is often lacking in the literature. The aim of this study was to investigate the impact of state-of-the-art 3D U-Net-generated organ delineations on dose optimization in radiation therapy (RT) for prostate cancer patients.
methodsA database of 69 computed tomography images with prostate, bladder, and rectum delineations was used for single-label 3D U-Net training with dice similarity coefficient (DSC)-based loss. Volumetric modulated arc therapy (VMAT) plans have been generated for both manual and automatic segmentations with the same optimization settings. These were chosen to give consistent plans when applying perturbations to the manual segmentations. Contours were evaluated in terms of DSC, average and 95% Hausdorff distance (HD). Dose distributions were evaluated with the manual segmentation as reference using dose volume histogram (DVH) parameters and a 3%/3 mm gamma-criterion with 10% dose cut-off. A Pearson correlation coefficient between DSC and dosimetric metrics, i.e. gamma index and DVH parameters, has been calculated.
results3D U-Net-based segmentation achieved a DSC of 0.87 (0.03) for prostate, 0.97 (0.01) for bladder and 0.89 (0.04) for rectum. The mean and 95% HD were below 1.6 (0.4) and below 5 (4) mm, respectively. The DVH parameters, V[Formula: see text] for the bladder and V[Formula: see text] for the rectum, showed agreement between dose distributions within [Formula: see text] and [Formula: see text], respectively. The D[Formula: see text] and V[Formula: see text], for prostate and its 3 mm expansion (surrogate clinical target volume) showed agreement with the reference dose distribution within 2% and 3 Gy with the exception of one case. The average gamma pass-rate was 85%. The comparison between geometric and dosimetric metrics showed no strong statistically significant correlation.
conclusionsThe 3D U-Net developed for this work achieved state-of-the-art geometrical performance. Analysis based on clinically relevant DVH parameters of VMAT plans demonstrated neither excessive dose increase to OARs nor substantial under/over-dosage of the target in all but one case. Yet the gamma analysis indicated several cases with low pass rates. The study highlighted the importance of adding dosimetric analysis to the standard geometric evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.